Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Comments Comments
  •  (3)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Abbott Hepatitis C Combo Impressive in Small Study

April 6, 2012

A combination of oral hepatitis C drugs being developed by Abbott Laboratories realized cure rates exceeding 90 percent in treatment-naïve patients, according to a small, mid-stage study. The results, released Wednesday, will be presented later this month in Barcelona at a meeting of the European Association for the Study of the Liver.

For 12 weeks, patients in the Phase II trial, known as "Co-Pilot," received Abbott's protease inhibitor ABT-450, boosted by the antiviral drug ritonavir with its polymerase inhibitor ABT-333, and ribavirin, which is used in all current hepatitis C regimens. Patients' blood virus levels were checked 24 weeks later for a sustained virologic response. Those achieving SVR were considered cured.

View Full Article


  
  • Email Email
  • Comments Comments
  •  (3)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 
See Also
Talk to a Physician About HIV/Hepatitis Coinfection in Our "Ask the Experts" Forums
More on Hepatitis C Drugs in Development

Reader Comments:

Comment by: Elaine (Texas) Fri., Apr. 20, 2012 at 12:05 pm EDT
What was the genotype of the patients?
Reply to this comment


Comment by: Mohammad F (Egypt) Fri., Apr. 20, 2012 at 11:28 am EDT
I am egyptian،and hope that patients with genotype 4 (v.Common in Egypt) be involved in such recent studies.
Reply to this comment


Comment by: Pat (michigan) Thu., Apr. 19, 2012 at 10:47 pm EDT
What are the side affects of the drug?
Reply to this comment


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement